Small Hospitals
Market Cap
₹6,651 ₹6,651 Cr.
P/E
25.95
PEG
2.34
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

The base thesis is driven by healthcare patient encounters and realization per encounter; patient volume is the larger execution risk because it depends on capacity, staffing and demand, while realization gains alone cannot reach the terminal case.

The bull path requires higher patient volume coinciding with higher realization; the bear path is a volume shortfall combined with realization weakness, with lower encounters accounting for most of the base-to-bear gap.

Watch the analyst triggers: combined encounters below 1.5 million in FY28 or blended realization below ₹11,800 for two consecutive quarters by FY29 would shift the model toward the bear drivers.

Key Ratios

Debt to Equity
Debt to Equity
0.28
Div Yield (%)
Div Yield (%)
0.25
Individual < 2 lac
Individual < 2 lac
20.19 %
Institutions
Institutions
5.50 %
Market cap
Market cap
6,651 Cr
No. of Shareholders
No. of Shareholders
19,362
OPM (%)
OPM (%)
27.85 %
PE
PE
25.95
Prom Holding
Prom Holding
56.52 %
ROCE (%)
ROCE (%)
20.77
ROE (%)
ROE (%)
18.53
Sales
Sales
1,643 Cr
  • Kovai Medical Center
  • Artemis MedicareServ
  • Jupiter Life Line
  • TJI Hospitals
Last updated on 14 Aug 2026
  • Kovai Medical Center and Hospital runs hospitals contributing ~93% of revenue alongside small medical education business.
  • Healthcare carries incremental growth and profit; education shrinking.
  • Hospital expansion underway with Chennai greenfield and main-campus paediatric build; Neurosciences block operational; shedding tiny courses business.
  • Balance sheet funding cushion supports hospital builds.
  • Heavy healthcare concentration leaves earnings tied to hospitals.
  • 300-bed paediatric hospital was Q2 2026; no update since
    construction start, cost and bed addition emerge.
  • Dr Arun N Palaniswami Joint Managing Director vote after 14 Aug 2026; no date stated
    shareholder approval settles succession continuity.
  • 40th AGM 26 Aug 2026
    settles ₹15 dividend and succession or related-party votes.
  • Courses unit sale completion by 30 Nov 2026
    ₹0.85Cr related-party sale exits 0.29% turnover.
  • Chennai 300–400-bed hospital No timeline
    update sets land, cost, funding and start date.
Price Range

See where the stock is trading versus its 52-week high and low.

Low
5010
52W Range
High
6725
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

12 Yes

Positive for this company

2 Neutral

Neutral for this company

3 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Product Wise Break-Up - Inpatients

Product Wise Break-Up - Outpatients

Location Wise Break-Up

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

    Select a Metric
    • Average Daily Revenue Per Occupied Bed (Rs)
    • Hospital Occupancy Rate (%)
    • Average Length Of Stay (Days)
    • Operational Beds (.)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Kovai Medical Center & Hospital Ltd. Business

    Kovai Medical Center and Hospital Limited (KMCH) is a multi-disciplinary super-specialty hospital in India with 657 beds, offering a wide range of medical disciplines and procedures including open heart surgeries, kidney transplants, and preventive health checkup programs.

    Kovai Medical Center major competitors are Artemis MedicareServ, Jupiter Life Line, Yatharth Hospital, Indraprastha Medical, Healthcare Global, Dr Agarwals Eye Hosp, KMC Speciality Hosp..
    Market Cap of Kovai Medical Center is ₹6,788 Crs.
    While the median market cap of its peers are ₹5,452 Crs.

    Kovai Medical Center seems to be less financially stable compared to its competitors.
    Altman Z score of Kovai Medical Center is 7.52 and is ranked 5 out of its 8 competitors.

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material